Bulletin
Investor Alert

Dec. 2, 2021, 5:44 a.m. EST

Array Instruments Market Report 2021-26: Industry Trends, Size, Share, Analysis and Forecast

Array Instruments Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Agilent Technologies Inc. (A)
  • X
    Bio-Rad Laboratories Inc. Cl A (BIO)
  • X
    Illumina Inc. (ILMN)

or Cancel Already have a watchlist? Log In

Dec 02, 2021 (Heraldkeepers) -- According to the latest report by IMARC Group, titled "Array Instruments Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," the global array instruments market exhibited moderate growth during 2015-2020. Looking forward, the market is expected to grow at a CAGR of 5.4% during 2021-2026.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Array instruments are devices that are used to collect microscopic spots of RNA, DNA, proteins, tissues, peptides, oligonucleotides, cells, and other compounds attached to a solid substrate. They are utilized in laboratories that quantitatively and simultaneously monitor the expression of multiple genes. The high-throughput approach of array technology helps to locate mutations and chromosomal expressions in a genotype, and measure and detect gene expressions at the messenger RNA (mRNA) or the protein level.

Request Free Sample Report: https://www.imarcgroup.com/array-instruments-market/requestsample

Market Trends

The primary factors driving the array instruments market are the emerging need for diagnosing cancer, post-natal and different metabolic diseases. These instruments assist in hybridization, coupling biomolecules to a platform, sample preparation for detection, data analysis, and scanning, which have increased their demand in recent times. Furthermore, governments across the globe have undertaken several initiatives to improve the healthcare infrastructure and increase investments in research and development (R&D) activities, which in turn have boosted the demand for array instruments. Moreover, the introduction of the latest technologies, such as microarray-based comparative genomic hybridization, has enhanced the process of single nucleotide polymorphism (SNP) and offers accuracy and precision in disease diagnosis and drug discovery, which in turn is expected to provide a positive impact on the industry.

Ask Analyst and Browse Full Report with TOC & List of Figure: https://bit.ly/2SwsSlF

List of Key Companies Covered in this Market Report:

Affymetrix Inc.
Agilent Technologies Inc. /zigman2/quotes/207081878/composite A -2.57%
Arrayit Corporation (otcmkts:ARYC)
Bio-RAD Laboratories /zigman2/quotes/207953537/composite BIO -1.55%
Inc. Illumina Inc. /zigman2/quotes/203509482/composite ILMN -5.53%
Laboratory Corporation /zigman2/quotes/203174601/composite LH -1.51%
Molecular Devices LLC
Raybiotech Inc.
Sigma Aldrich Corporation
Thermo Fisher Scientific Inc. /zigman2/quotes/201150432/composite TMO -1.40%

Key Segments of the Report:

Breakup by Application:

Molecular Biology
Cell Biology
Genetics
Molecular Pathology
Others

Breakup by Technology:

DNA Microarrays
Protein Microarrays
Cellular Microarrays
Tissue Microarrays

Breakup by End-User:

Research and Development Laboratories
Clinical Diagnostic Labs
Agriculture Research Centers
Veterinary Laboratories
Forensic Centers
Others

Breakup by Geography:

/zigman2/quotes/207081878/composite
US : U.S.: NYSE
$ 134.57
-3.55 -2.57%
Volume: 1.71M
Jan. 25, 2022 4:02p
P/E Ratio
34.09
Dividend Yield
0.62%
Market Cap
$41.71 billion
Rev. per Employee
$371,706
loading...
/zigman2/quotes/207953537/composite
US : U.S.: NYSE
$ 574.93
-9.03 -1.55%
Volume: 400,201
Jan. 25, 2022 4:04p
P/E Ratio
2.61
Dividend Yield
N/A
Market Cap
$17.39 billion
Rev. per Employee
$372,452
loading...
/zigman2/quotes/203509482/composite
US : U.S.: Nasdaq
$ 344.76
-20.20 -5.53%
Volume: 1.18M
Jan. 25, 2022 4:00p
P/E Ratio
56.72
Dividend Yield
N/A
Market Cap
$57.04 billion
Rev. per Employee
$548,718
loading...
/zigman2/quotes/203174601/composite
US : U.S.: NYSE
$ 268.05
-4.10 -1.51%
Volume: 924,200
Jan. 25, 2022 4:00p
P/E Ratio
9.52
Dividend Yield
N/A
Market Cap
$26.04 billion
Rev. per Employee
$228,655
loading...
/zigman2/quotes/201150432/composite
US : U.S.: NYSE
$ 567.75
-8.05 -1.40%
Volume: 1.86M
Jan. 25, 2022 4:00p
P/E Ratio
26.36
Dividend Yield
0.18%
Market Cap
$226.89 billion
Rev. per Employee
$488,238
loading...
1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.